Christopher S. Henney - 14 Jul 2021 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role
Director
Signature
/s/ Karin L. Walker, as Attorney in Fact for Christopher Henney
Issuer symbol
PRTA
Transactions as of
14 Jul 2021
Net transactions value
-$490,166
Form type
4
Filing time
16 Jul 2021, 16:02:21 UTC
Previous filing
13 Jul 2021
Next filing
16 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTA Ordinary Shares, par value $0.01 per share Options Exercise $125,854 +11,108 $11.33 11,108 14 Jul 2021 Direct
transaction PRTA Ordinary Shares, par value $0.01 per share Sale $503,757 -9,108 -82% $55.31 2,000 14 Jul 2021 Direct F1, F2
transaction PRTA Ordinary Shares, par value $0.01 per share Sale $112,263 -2,000 -100% $56.13 0 14 Jul 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRTA Stock Option (Right to Buy) Options Exercise $0 -11,108 -100% $0.000000* 0 14 Jul 2021 Ordinary Shares 11,108 $11.33 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $55.00 to $55.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The transaction was executed in multiple trades in prices ranging from $56.005 to $56.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The shares subject to the option were fully vested as of the date of the exercise.